Pages that link to "Q27022482"
Jump to navigation
Jump to search
The following pages link to Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis (Q27022482):
Displaying 50 items.
- The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis (Q26748194) (← links)
- Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis (Q26751553) (← links)
- Neutrophils in Cancer: Two Sides of the Same Coin (Q26773072) (← links)
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysis (Q26773406) (← links)
- Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis (Q26786160) (← links)
- Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives (Q26795526) (← links)
- Immune cell promotion of metastasis (Q26991724) (← links)
- The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis (Q28067745) (← links)
- Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis (Q28070039) (← links)
- Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma (Q28077206) (← links)
- Blood Biomarkers of Chronic Inflammation in Gulf War Illness (Q28397945) (← links)
- Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis (Q28552296) (← links)
- Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. (Q30878925) (← links)
- Frailty and inflammatory markers in older adults with cancer (Q33563551) (← links)
- Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. (Q33563950) (← links)
- Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies (Q33591876) (← links)
- Baseline serum albumin and other common clinical markers are prognostic factors in colorectal carcinoma: A retrospective cohort study (Q33597365) (← links)
- Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis (Q33602512) (← links)
- Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis (Q33607108) (← links)
- The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients (Q33624392) (← links)
- The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. (Q33660069) (← links)
- CA125 modified by PLT and NLR improves the predictive accuracy of adenomyosis-derived pelvic dense adhesion (Q33672889) (← links)
- Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma (Q33674802) (← links)
- Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer (Q33685545) (← links)
- Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma. (Q33717537) (← links)
- Myeloid cells in circulation and tumor microenvironment of breast cancer patients (Q33729434) (← links)
- Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy (Q33736271) (← links)
- Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC. (Q33749070) (← links)
- Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis (Q33762053) (← links)
- Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies (Q33762117) (← links)
- IL-35 induces N2 phenotype of neutrophils to promote tumor growth (Q33779538) (← links)
- Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species. (Q33829292) (← links)
- Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans. (Q33862472) (← links)
- Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort (Q33863437) (← links)
- Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling (Q33907380) (← links)
- Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. (Q33994334) (← links)
- Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects (Q34466236) (← links)
- Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils (Q35090032) (← links)
- Predictive contribution of neutrophil/lymphocyte ratio in diagnosis of brucellosis. (Q35097382) (← links)
- Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer (Q35220302) (← links)
- The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. (Q35274955) (← links)
- Salvage systemic therapy for advanced urothelial carcinoma: on the cusp of a sea change? (Q35586740) (← links)
- Neutrophil-to-Lymphocyte Ratio Is Associated with Impaired Interferon-Gamma Release to Phytohemagglutinin (Q35592976) (← links)
- Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients (Q35663441) (← links)
- The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy (Q35677849) (← links)
- Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study (Q35755373) (← links)
- Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer (Q35790197) (← links)
- Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma (Q35797850) (← links)
- Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. (Q35863154) (← links)
- The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study. (Q36034748) (← links)